comparemela.com

Luca Mastorino News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study Compares Benefits of Treating Inverse Psoriasis with IL-17, IL-23 Inhibitors

This retrospective, systematic review highlighted the lack of studies specifically addressing the needs of patients with inverse psoriasis.

Luca mastorinoUniversity of turin departmentDermatology clinic of turin university hospitalDermatology clinicTurin university hospitalPsoriasis areaSeverity index

Ixekizumab Shown to be Safe, Effective for Up to 5 Years for Psoriasis

These data on ixekizumab in real-world settings shed light on drug survival information for both those with psoriasis and those with psoriatic arthritis.

Dermatol venereolLuca mastorinoDermatologic clinic of the university turinUniversity of turinDermatologic clinicMedical sciencesDermatology life quality indexEur acad dermatolOpin biol15 year

vimarsana © 2020. All Rights Reserved.